Knowledge

Brent Saunders

Source 📝

271:
in 2019. In September, Saunders’ special-purpose acquisition company Vesper Healthcare Acquisition publicly launched, and raised $ 400 million. Filings indicated that Saunders owned 20% of the company after the SPAC sale. In December, Saunders made his first deal with Vesper, acquiring HydraFacial, a
188:
as a healthcare compliance manager, and became partner and head of the firm's compliance business advisory services group. In October 2003, Saunders was hired as senior vice president of global compliance and business practices at
275:
In May 2021, Vesper's HydraFacial deal closed, and the new company was renamed The Beauty Health Company, with Saunders taking the role of executive chairman. He also served as interim CEO until February 2022.
286:
In March 2023, Saunders returned to Bausch + Lomb as CEO and chairman. In June, Saunders signed his first deal as CEO, purchasing dry eye drug Xiidra from Novartis for $ 1.75 billion.
481: 566: 393: 193:, a pharmaceutical company. In mid-2007, he became president of consumer health care at Schering-Plough, with responsibility for a business unit of products including 580: 153:, where he was president of the student government board, and graduated in 1992 with a bachelor's degree in economics and East Asian studies. In 1996, he received 514: 606: 736: 658: 122:(SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America. 684: 450: 228:, for $ 8.7 billion. He joined Valeant in an advisory role to assist with the transition. In October, Saunders joined pharmaceutical company 710: 329: 143: 256:
magazine, where he was named as "Wall Street's Drug Dealer". In May 2019, Saunders survived a proposal brought by hedge fund
130:
Saunders was born in 1969 or 1970 to Charles and Sheila Saunders, a urologist and social worker. He grew up in the
803: 139: 119: 762: 362: 836: 788: 154: 424: 247:, a pharmaceutical company, for a reported $ 70.5 billion. The new combined company took the Allergan name. 632: 279:
In June 2022, Saunders was named to the board of medical aesthetics company Hugel America, an affiliate of
394:"HydraFacial merges with Vesper Healthcare to form new, publicly traded company based in Long Beach" 150: 90:(1969 or 1970) is an American biopharma executive and entrepreneur who is the chairman and 41: 268: 221: 107: 831: 185: 567:"Bausch & Lomb Brent Saunders Named to New York's Federal Reserve Regional Advisory Board" 711:"AbbVie, nearing the end of Humira's historic run, scoops up a struggling Allergan for $ 63B" 515:"Back to beauty: Former Allergan chief Saunders scoops up aesthetics company in $ 1.1B deal" 826: 257: 8: 240: 229: 540: 267:
In June 2020, Saunders joined the board of BridgeBio Pharma, a company founded with an
162: 49: 213: 178: 95: 217: 198: 190: 103: 98:. He helped lead various mergers and acquisitions, including the mergers between 685:"Allergan CEO Saunders gets to keep chairmanship after failed investor campaign" 659:"Allergan CEO Saunders puts on chairman's cap as Actavis architect Bisaro exits" 220:
advisory board. In 2013, as CEO of Bausch + Lomb, he oversaw its acquisition by
330:"Brent Saunders, Parkland grad, is the Lehigh Valley's $ 150 billion dealmaker" 65: 205:. In 2009, Saunders led the integration team of Schering-Plough's merger with 820: 225: 131: 260:
to split Allergan's chairman and CEO roles. In June, pharmaceutical company
177:
In 1996, while attending law school, Saunders started working part time at
166: 158: 135: 53: 280: 206: 99: 737:"Saunders finds life after Allergan on board at newly IPO'ed BridgeBio" 194: 482:"This Giant Drug Firm Won't Invent Medicines. Investors Are Cheering" 607:"Forest Labs names ex-Bausch & Lomb head Brent Saunders as CEO" 244: 202: 111: 236: 138:, with a twin brother Wayne and sister Reed, and graduated from 261: 252: 115: 581:"Drugmaker Valeant to buy Bausch & Lomb for $ 8.7 billion" 363:"Brent Saunders rides $ 400M wave to the top of the SPAC boom" 451:"Allergan: Pharma's Biggest Dealmaker Is On The Hunt Again" 235:
In May 2014, Saunders was named chief executive officer of
541:"Brent Saunders, Bausch & Lomb CEO: The Eyes Have It" 216:, an eye health company. In 2010 he was appointed to the 91: 45: 633:"Forest Labs' Saunders to Head Actavis When Deal Closes" 243:. In November, Saunders negotiated Actavis' merger with 212:
In 2010, Saunders was appointed chief executive officer
239:, a pharmaceutical company, after the company acquired 804:"Bausch + Lomb's CEO Inks First Big Deal Since Return" 250:
In February 2015, Saunders appeared on the cover of
818: 791:. February 15, 2023 – via www.reuters.com. 789:"Brent Saunders to return as Bausch + Lomb CEO" 425:"Ex-Allergan CEO Joins Parent of Botox Rival" 272:beauty treatment company, for $ 1.1 billion. 16:American biopharma executive and entrepreneur 125: 763:"Beauty Health Names Andrew Stanleick CEO" 509: 507: 505: 503: 476: 474: 472: 357: 355: 353: 351: 324: 322: 320: 318: 599: 573: 316: 314: 312: 310: 308: 306: 304: 302: 300: 298: 69:Founder of Vesper Healthcare Acquisition 801: 729: 703: 677: 651: 419: 417: 415: 819: 500: 469: 443: 348: 144:South Whitehall Township, Pennsylvania 110:, and the $ 63 billion acquisition of 106:, the acquisition of Bausch + Lomb by 755: 533: 388: 386: 384: 295: 71:Chairman of The Beauty Health Company 625: 412: 264:acquired Allergan for $ 63 billion. 802:Hopkins, Jared S. (June 30, 2023). 120:special-purpose acquisition company 13: 381: 14: 848: 81:Biopharma executive, entrepreneur 795: 781: 559: 429:Orange County Business Journal 1: 289: 767:Los Angeles Business Journal 7: 398:Long Beach Business Journal 10: 853: 181:as a compliance officer. 837:American chief executives 184:In 2000, Saunders joined 172: 77: 73:Chairman of Hugel America 60: 36: 28: 21: 810:– via www.wsj.com. 151:University of Pittsburgh 126:Early life and education 42:University of Pittsburgh 222:Valeant Pharmaceuticals 118:. He is the founder of 108:Valeant Pharmaceuticals 186:PricewaterhouseCoopers 94:of the health company 613:. September 10, 2013 369:. September 30, 2020 258:Appaloosa Management 140:Parkland High School 64:Chairman and CEO of 808:Wall Street Journal 637:Wall Street Journal 241:Forest Laboratories 230:Forest Laboratories 56:, Temple University 769:. January 21, 2022 665:. October 27, 2016 521:. December 9, 2020 336:. October 19, 2015 283:-based Hugel Inc. 134:region of eastern 214:Bausch & Lomb 163:Temple University 96:Bausch & Lomb 85: 84: 50:Temple University 844: 812: 811: 799: 793: 792: 785: 779: 778: 776: 774: 759: 753: 752: 750: 748: 733: 727: 726: 724: 722: 707: 701: 700: 698: 696: 681: 675: 674: 672: 670: 655: 649: 648: 646: 644: 629: 623: 622: 620: 618: 603: 597: 596: 594: 592: 587:. March 21, 2011 577: 571: 570: 563: 557: 556: 554: 552: 547:. March 21, 2011 537: 531: 530: 528: 526: 511: 498: 497: 495: 493: 488:. March 21, 2011 478: 467: 466: 464: 462: 447: 441: 440: 438: 436: 421: 410: 409: 407: 405: 390: 379: 378: 376: 374: 359: 346: 345: 343: 341: 334:The Morning Call 326: 179:Jefferson Health 149:He attended the 32:February 6, 1970 19: 18: 852: 851: 847: 846: 845: 843: 842: 841: 817: 816: 815: 800: 796: 787: 786: 782: 772: 770: 761: 760: 756: 746: 744: 743:. June 24, 2020 735: 734: 730: 720: 718: 717:. June 25, 2019 709: 708: 704: 694: 692: 683: 682: 678: 668: 666: 657: 656: 652: 642: 640: 631: 630: 626: 616: 614: 605: 604: 600: 590: 588: 579: 578: 574: 565: 564: 560: 550: 548: 545:Chief Executive 539: 538: 534: 524: 522: 513: 512: 501: 491: 489: 480: 479: 470: 460: 458: 457:. July 27, 2015 449: 448: 444: 434: 432: 431:. June 21, 2022 423: 422: 413: 403: 401: 392: 391: 382: 372: 370: 361: 360: 349: 339: 337: 328: 327: 296: 292: 224:, now known as 218:Federal Reserve 191:Schering-Plough 175: 128: 104:Schering-Plough 72: 70: 68: 52: 44: 37:Alma mater 24: 17: 12: 11: 5: 850: 840: 839: 834: 829: 814: 813: 794: 780: 754: 728: 702: 676: 650: 639:. May 14, 2014 624: 598: 572: 558: 532: 499: 468: 442: 411: 380: 367:Endpoints News 347: 293: 291: 288: 174: 171: 127: 124: 88:Brent Saunders 83: 82: 79: 78:Known for 75: 74: 62: 58: 57: 38: 34: 33: 30: 26: 25: 23:Brent Saunders 22: 15: 9: 6: 4: 3: 2: 849: 838: 835: 833: 832:Living people 830: 828: 825: 824: 822: 809: 805: 798: 790: 784: 768: 764: 758: 742: 741:Fierce Pharma 738: 732: 716: 715:Fierce Pharma 712: 706: 691:. May 1, 2019 690: 689:Fierce Pharma 686: 680: 664: 663:Fierce Pharma 660: 654: 638: 634: 628: 612: 608: 602: 586: 582: 576: 568: 562: 546: 542: 536: 520: 519:Fierce Pharma 516: 510: 508: 506: 504: 487: 483: 477: 475: 473: 456: 452: 446: 430: 426: 420: 418: 416: 400:. May 7, 2021 399: 395: 389: 387: 385: 368: 364: 358: 356: 354: 352: 335: 331: 325: 323: 321: 319: 317: 315: 313: 311: 309: 307: 305: 303: 301: 299: 294: 287: 284: 282: 277: 273: 270: 265: 263: 259: 255: 254: 248: 246: 242: 238: 233: 231: 227: 226:Bausch Health 223: 219: 215: 210: 208: 204: 200: 196: 192: 187: 182: 180: 170: 168: 164: 161:degrees from 160: 156: 152: 147: 145: 141: 137: 133: 132:Lehigh Valley 123: 121: 117: 113: 109: 105: 101: 97: 93: 89: 80: 76: 67: 66:Bausch + Lomb 63: 61:Occupation(s) 59: 55: 51: 47: 43: 39: 35: 31: 27: 20: 807: 797: 783: 771:. Retrieved 766: 757: 745:. Retrieved 740: 731: 719:. Retrieved 714: 705: 693:. Retrieved 688: 679: 667:. Retrieved 662: 653: 641:. Retrieved 636: 627: 615:. Retrieved 610: 601: 589:. Retrieved 584: 575: 561: 549:. Retrieved 544: 535: 523:. Retrieved 518: 490:. Retrieved 485: 459:. Retrieved 454: 445: 433:. Retrieved 428: 402:. Retrieved 397: 371:. Retrieved 366: 338:. Retrieved 333: 285: 278: 274: 266: 251: 249: 234: 211: 199:Dr. Scholl's 183: 176: 167:Philadelphia 148: 136:Pennsylvania 129: 87: 86: 40:Bachelor's, 827:1970 births 281:South Korea 146:in 1988. 821:Categories 290:References 195:Coppertone 773:July 11, 747:July 11, 721:July 11, 695:July 11, 669:July 11, 643:July 11, 617:July 11, 591:July 11, 551:July 11, 525:July 11, 492:July 11, 461:July 11, 435:July 11, 404:July 11, 373:July 11, 340:July 11, 245:Allergan 232:as CEO. 203:Claritin 112:Allergan 611:Reuters 585:Reuters 237:Actavis 486:Forbes 455:Forbes 262:Abbvie 253:Forbes 201:, and 173:Career 116:Abbvie 207:Merck 100:Merck 775:2022 749:2022 723:2022 697:2022 671:2022 645:2022 619:2022 593:2022 553:2022 527:2022 494:2022 463:2022 437:2022 406:2022 375:2022 342:2022 159:J.D. 157:and 102:and 29:Born 269:IPO 165:in 155:MBA 142:in 114:by 92:CEO 46:MBA 823:: 806:. 765:. 739:. 713:. 687:. 661:. 635:. 609:. 583:. 543:. 517:. 502:^ 484:. 471:^ 453:. 427:. 414:^ 396:. 383:^ 365:. 350:^ 332:. 297:^ 209:. 197:, 169:. 54:JD 48:, 777:. 751:. 725:. 699:. 673:. 647:. 621:. 595:. 569:. 555:. 529:. 496:. 465:. 439:. 408:. 377:. 344:.

Index

University of Pittsburgh
MBA
Temple University
JD
Bausch + Lomb
CEO
Bausch & Lomb
Merck
Schering-Plough
Valeant Pharmaceuticals
Allergan
Abbvie
special-purpose acquisition company
Lehigh Valley
Pennsylvania
Parkland High School
South Whitehall Township, Pennsylvania
University of Pittsburgh
MBA
J.D.
Temple University
Philadelphia
Jefferson Health
PricewaterhouseCoopers
Schering-Plough
Coppertone
Dr. Scholl's
Claritin
Merck
Bausch & Lomb

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.